化合物 T14831
中文名称 | 化合物 T14831 |
---|---|
中文同义词 | 苔藓抑素1;化合物 T14831;BRYOSTATIN 1,蛋白KINASE C活化剂 |
英文名称 | BRYOSTATIN 1 |
英文同义词 | BRYOSTATIN 1;BRYO 1;BRYOSTATIN;bryostatin1,0;(26R)-Bryostatin 1;NSC-339555;(1S,3S,5Z,7R,8E,11S,12S,13E,15S,17R,21R,23R,25S)-25-(Acetyloxy)-1,11,21-trihydroxy-17-[(1R)-1-hydroxyethyl]-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl2,4-octadienoicacidester;2,4-Octadienoic acid, (1S,3S,5Z,7R,8E,11S,12S,13E,15S,17R,21R,23R,25S)-25-(acetyloxy)-1,11,21-trihydroxy-17-(1R)-1-hydroxyethyl-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo21.3.1.13,7.111,15nonacos-8-en |
CAS号 | 83314-01-6 |
分子式 | C47H68O17 |
分子量 | 905.03 |
EINECS号 | |
相关类别 | 对照品;Cell Signaling and Neuroscience;Kinase/Phosphatase Biology;Protein Kinase ActivatorsSerine/Threonine Kinase Biology;Protein Kinase C (PKC);Serine/Threonine Kinase Activators;inhibitor |
Mol文件 | 83314-01-6.mol |
结构式 | ![]() |
化合物 T14831 性质
熔点 | 230-235° |
---|---|
比旋光度 | D25 +34.1° (c = 0.044 in methanol) |
沸点 | 716.44°C (rough estimate) |
密度 | 1.1245 (rough estimate) |
折射率 | 1.5940 (estimate) |
储存条件 | -20°C |
溶解度 | 可溶于DMSO |
酸度系数(pKa) | 11.10±0.70(Predicted) |
形态 | 固体 |
颜色 | 白色 |
旋光性 (optical activity) | +34.125 (methanol) |
PKC
HIV-1
Bryostatin 1 (1 µM; 5 minutes; HT22 cells) treatment successfully recruits Munc13-1 from the cytosol to the plasma membrane. Effects of Bryostatin 1 on the other Munc13 family members, ubMunc13-2 and bMunc13-2, resembled those of Munc13-1 for translocation .
The increased level of expression of Munc13-1 following a 24 h incubation with Bryostatin 1 in both HT22 and primary mouse hippocampal cells is observed.
Bryostatin 1 can also affect the immune system by modulating dendritic cells (DCs) via toll-like receptor 4 (TLR4) through the MyD88-independent pathway, which favors an anti-inflammatory environment by inducing a type 2 phenotype that promotes the differentiation of CD4
+
T-helper (Th) lymphocytes into Th2 versus Th1 effector cells.
Western Blot Analysis
Cell Line: | HT22 cells |
Concentration: | 1 µM |
Incubation Time: | 5 minutes |
Result: | Caused Munc13-1 to transfer to the membrane fraction. |
Bryostatin 1 (30 μg/kg; intraperitoneal injection; 3 d per week; for 2 weeks; C57BL/6J mice) treatment abolishes the onset of EAE.
Animal Model: | Female C57BL/6J mice (8-12-week-old) with MOG 35-55 |
Dosage: | 30 μg/kg |
Administration: | Intraperitoneal injection; 3 d per week; for 2 weeks |
Result: | Abolished the onset of experimental autoimmune encephalomyelitis (EAE). |
安全信息
危险品标志 | Xn |
---|---|
危险类别码 | 68 |
安全说明 | 22-24/25-36/37 |
WGK Germany | 3 |
RTECS号 | EH9455000 |
海关编码 | 2932990090 |
毒性 | LD50 in mice, rats (mg/kg): 0.038, 0.068 i.v. (Prendiville) |
提供商 | 语言 |
---|---|
英文
|
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2025/02/08 | HY-105231 | 化合物 T14831 Bryostatin 1 | 83314-01-6 | 10μg | 5200元 |